EPIVARIO
EpiVario is a preclinical pharmaceutical company that develops novel compounds for the goal of reducing or preventing the pathogenesis of psychiatric diseases: post-traumatic stress disorder (PTSD) and substance abuse disorders. EpiVario was founded in 2017 and is based in Philadelphia, Pennsylvania.
EPIVARIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.epivario.com
Total Employee:
11+
Status:
Active
Contact:
(215) 400.0133
Total Funding:
445 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx Google Apps For Business YouTube UNPKG Unified Layer MailChimp
Similar Organizations
Abyssinia Biologics
Abyssinia is altering the world's understanding of Alzheimer's Disease from diagnostic assays with the potential for early diagnosis.
Aconabolics
Aconabolics specializes in the synthesis of organic acids, keto acids, and amino acids for diagnostics pharmaceutical research.
Adenovir Pharma
Adenovir Pharma develops solutions for the treatment of infectious diseases affecting the eyes.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
CELLnLIFE
CELLnLIFE develops stem cell therapy for the treatment of rare and intractable diseases.
Ceregene
Ceregene is a biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Claritox Pro (First Reviews)
Claritox Pro review, take a look at how the supplement works, its ingredients, Click Below Link To Order
Cyclone Therapeutics
"Black belt chemistry" on natural products targeting the biology of aging and proteostasis. A spinout of The Scripps Research Institute.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Gannex
Gannex is dedicated to the R&D and commercialization of new drugs in the field of NASH.
Hoverink
Hoverink aims to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments.
Inspired Life Medical
Inspired Life Medical develops a reproducible screening tool for the purpose of identifying Alzheimer’s disease.
iReprogram
iReprogram is a cell regeneration lab that aims to expedite the delivery of next-generation personalized medicine.
MacuCLEAR
MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye.
MedaSystems
Expanded Access software for biopharmaceuticals
Mindset Pharma
Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
PanCryos
PanCryos develops a next generation stem cell derived allogenic cell therapy or Type 1 diabetes.
PharmoRx Therapeutics, Inc.
Discovering novel therapies for treatment resistant depression and other dopamine-related diseases
Plex Research
Plex Research is the Boston area start-up that's transforming the humble search bar into a drug discovery powerhouse.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Silkim Pharma
Silkim Pharma develops a novel, protected platform of drugs for proven treatments of multiple indications.
US Bioservices
Providing trusted patient support for over 20 years, US Bioservices is AmerisourceBergen’s independent specialty pharmacy.
Vector Vitale
Vector Vitale is creating therapeutic solutions that provide symmetry correction of biomolecules.
Verde Technologies
Verde Technologies invented a product that can reduce the risk of drug misuse and protect the environment.
Wright Avenue Partners
Wright Avenue Partners deliver Functional Service Provider (FSP) and specialty resourcing solutions.
Current Employees Featured
Founder
Official Site Inspections
http://www.epivario.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: 108-167-164-144.unifiedlayer.com
- IP address: 108.167.164.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "EpiVario"
Epivario
EpiVario is an innovation focused biotechnology company that is developing neuroepigenetic modulators to treat memory related addiction and psychiatric disorders.See details»
EpiVario - Crunchbase Company Profile & Funding
EpiVario is a preclinical pharmaceutical company that develops novel compounds for the goal of reducing or preventing the pathogenesis of psychiatric …See details»
EpiVario, Inc. | LinkedIn
EpiVario, Inc. | 1,074 followers on LinkedIn. EpiVario is using epigenetics to treat memory related psychiatric diseases incl PTSD and alcohol and drug addiction | EpiVario is a preclinical stage …See details»
EpiVario 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for EpiVario. Use the PitchBook Platform to explore the full profile.See details»
EpiVario Company Profile - Office Locations, Competitors ... - Craft
EpiVario has 5 employees at their 1 location and $445 k in total funding,. See insights on EpiVario including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
EpiVario Inc. - Executive Bio, Top Executies, and Transitions
View the organization profile of EpiVario Inc.,THOMAS KIM is an experienced corporate attorney and a registered patent attorney, and has served as the senior in-house counsel for Inovio, …See details»
EpiVario | Seed
EpiVario Inc. is developing innovative therapeutics targeting a newly identified epigenetic process involved in trauma-induced fear and stress responses and addiction-related drug cravings. …See details»
EpiVario, Inc. - app.biopharmiq.com
About: EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders. Our co-founders, Dr. Shelley Berger and Dr. Philipp Mews, are leaders in the field of …See details»
EpiVario – SEED2TABLE
Feb 27, 2025 EpiVario EpiVario Inc. is pioneering epigenetic therapeutics for modern-day treatments of neuropsychiatric disorders. Spun out of the Epigenetics Institute of the University of Pennsylvania, the company develops …See details»
EpiVario Company Profile | Management and Employees List
EpiVario Profile and History EpiVario is a preclinical stage drug discovery and development company that targets a wide range of memory-related psychiatric disorders, including PTSD, …See details»
EpiVario Inc. Company Profile | Philadelphia, PA | Competitors ...
Find company research, competitor information, contact details & financial data for EpiVario Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Targeting Substance Use Disorders - Epivario
Available treatments lack efficacy because the distress associated with the original trauma memory remains. EpiVario’s treatment focuses on reducing this distress; and, thereby, …See details»
EpiVario, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore EpiVario, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, and 1 literature, Technology Platform:Small molecule drug, Drug:EPV-001 ...See details»
EpiVario - Creative Destruction Lab
EpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of …See details»
EpiVario - VentureRadar
EpiVario is a preclinical stage biotechnology company that is developing neuroepigenetic modulators to treat memory related psychiatric disorders. EpiVario Inc. is pioneering …See details»
EpiVario - Funding, Financials, Valuation & Investors
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.See details»
EpiVario Awarded SBIR Grant From NIH to Develop Treatments for …
Oct 1, 2024 By targeting this pathway, EpiVario is developing an acute treatment designed to diminish triggered responses, promoting abstinence and preventing relapse in patients with …See details»
Epivario
Our Work on Opioid Addiction Nicotine Remains a Tremendous Market Opportunity … And Is Costing Healthcare Billions Addiction Creates a Socioeconomic Disadvantage 88.7% of Black …See details»
July 2022 Investor Update - Epivario
In the first half of the year, we applied for a number of grant funding opportunities and participated in various investor pitch events including, most recently, Startup Stadium at the BIO …See details»
Epivario
I agreed to consult and advise Epivario because of the novelty of its epigenetic target, and the outstanding team of scientists. I look forward to helping guide preclinical development of their …See details»